Full Text View
Tabular View
No Study Results Posted
Related Studies
Vitamin D Deficiency and Low Bone Mineral Content in Children (VDS)
This study is currently recruiting participants.
Verified by University of Massachusetts, September 2008
First Received: September 18, 2008   Last Updated: September 19, 2008   History of Changes
Sponsored by: University of Massachusetts
Information provided by: University of Massachusetts
ClinicalTrials.gov Identifier: NCT00756899
  Purpose

The Vitamin D study is designed to investigate the effect of body fat mass on vitamin D levels in children. Earlier studies have shown that individuals with increased fat mass may have low vitamin D levels.

Our specific hypothesis states that children with increased fat mass will have lower blood levels of vitamin D when compared to non-obese children.Since vitamin D is the primary hormone for bone mineralization in humans, low levels of vitamin D could lead to decreased bone mineral content in these children.


Condition
Vitamin D Deficiency
Obesity

MedlinePlus related topics: Minerals Obesity Obesity in Children
Drug Information available for: Vitamin D
U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Prospective
Official Title: The Relationship Between Vitamin D Deficiency and Low Bone Mineral Content in Children

Further study details as provided by University of Massachusetts:

Primary Outcome Measures:
  • Bone mineral content [ Time Frame: Baseline ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 50
Study Start Date: July 2008
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Obese
Chilren with BMI of >95th percentile
Non-obese
Children with BMI of <85th percentile

Detailed Description:

Fifty prepubertal male and female children of ages between 3-12 years will participate in this study. Of these, 25 obese children will be enrolled in the study group, and 25 non-obese children will serve as controls.

All subjects will fill out a comprehensive mineral intake questionnaire as part of the study to ensure adequate calcium intake prior to the study.

All subjects will collect a first morning urine sample for calcium, creatinine, and NTX.

Fasting blood samples will be drawn for the following analytes: 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D, intact PTH, calcium, phosphorus, magnesium, osteocalcin, insulin, c-peptide, fasting blood glucose, leptin, and adiponectin.

Bone Mineral Content will be evaluated in 16 obese subjects with vitamin D level of < 30 nmol/L.

  Eligibility

Ages Eligible for Study:   3 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Prepubertal children

Criteria

Inclusion Criteria:

  • General: Prepubertal children (males, with testicular volume of ≤ 3 cc, and girls with Tanner 1 breast) of ages 7-11 years will be enrolled in the study.
  • Study group: Subjects with a BMI of > 95th percentile for age and sex.
  • Control group: All control subjects will have a BMI of < 85th percentile for age and sex.

Exclusion Criteria:

  • known metabolic or genetic diseases resulting in obesity such as severe hypothyroidism, pseudohypoparathyroidism, or Cushing's disease
  • diabetes mellitus
  • subjects on lipid lowering medications
  • subjects on medications known to impact body weight or calcium homeostasis
  • subjects with a history of recent significant weight loss or gain
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00756899

Contacts
Contact: Benjamin U Nwosu, MD 508-334-7872 nwosub@ummhc.org
Contact: Mary M Lee, MD 508-856-4280 leeM@ummhc.org

Locations
United States, Massachusetts
University of Massachusetts Medical School Recruiting
Worcester, Massachusetts, United States, 01655
Contact: Benjamin U Nwosu, MD     508-334-7872     nwosub@ummhc.org    
Contact: Mary M Lee, MD     508-856-4287     LeeM@ummhc.org    
Principal Investigator: Benjamin U Nwosu, MD            
Sub-Investigator: Mary M Lee, MD            
Sub-Investigator: Olga T Hardy, MD            
Sub-Investigator: Leslie A Soyka, MD            
Sub-Investigator: Amanda Angelescu, MD            
Sub-Investigator: Lynn Norris, PA            
Sub-Investigator: Peter Simkin, MD            
Sub-Investigator: Carol A Ciccarelli, RN            
Sponsors and Collaborators
University of Massachusetts
Investigators
Principal Investigator: Benjamin U Nwosu, MD University of Massachusetts Medical School
Study Director: Carol A Cicarrelli, RN University of Massachusetts Medical School
  More Information

No publications provided

Responsible Party: University of Massachusetts Medical School ( Benjamin U. Nwosu, MD )
Study ID Numbers: H-12795
Study First Received: September 18, 2008
Last Updated: September 19, 2008
ClinicalTrials.gov Identifier: NCT00756899     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Massachusetts:
Vitamin D deficiency, insulin resistance, obesity, bone

Study placed in the following topic categories:
Vitamin D Deficiency
Obesity
Avitaminosis
Trace Elements
Bone Density Conservation Agents
Overweight
Insulin
Body Weight
Signs and Symptoms
Malnutrition
Vitamin D
Vitamins
Nutrition Disorders
Overnutrition
Micronutrients
Insulin Resistance
Deficiency Diseases

Additional relevant MeSH terms:
Vitamin D Deficiency
Obesity
Avitaminosis
Growth Substances
Physiological Effects of Drugs
Overweight
Bone Density Conservation Agents
Pharmacologic Actions
Body Weight
Signs and Symptoms
Malnutrition
Vitamin D
Vitamins
Nutrition Disorders
Overnutrition
Micronutrients
Deficiency Diseases

ClinicalTrials.gov processed this record on May 07, 2009